| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4215930 | Revue des Maladies Respiratoires Actualités | 2012 | 4 Pages |
Abstract
The large number of negative studies makes this disease a orphan cancer of therapeutic results. Inclusion of patients in clinical trials is warranted to improve survival in SCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
N. Baize,